AusBiotech is honoured to announce the establishment of the Depaz Oration, an annual keynote to be introduced at the AusBiotech Conference in 2025 in ...

Sanofi will take the lead co-commercialization role for our ... The trial will enroll adults aged 65 years and older and is ...

The company is banking on revenue from its Sanofi deal and vaccines in development ... Trump as U.S. president will be a boon ...

An emperor penguin that was found on a remote Western Australian beach on Nov. 1 is now being cared for by a registered carer ...

Pregnant mums and newborns will receive free vaccinations against respiratory syncytial virus (RSV) under the federal ...

In terms of industry tailwinds, Trump could lessen pressure from the Federal Trade Commission on mergers and acquisitions, ...

While uncertainty often casts a shadow on the Street, U.S. investors welcomed the presidential and congressional election ...

Despite diagnostic and therapeutic advances, mortality and the multi-systemic health impact of SMA continue to be experienced ...

Celltrion Inc. posted preclinical study results of two new antibody-drug conjugate (ADC) candidates – CT-P70 and CT-P71 – at ...

Birds and humans have different types of receptors in their respiratory tract that flu viruses attach to, like a lock ...

Sanofi will also look to develop a COVID/Influenza ... and although Novavax secured approvals in the UK, Canada, Australia, Switzerland, Singapore and New Zealand, and thanks to a partnership ...

While the inquiry gets most things right, as vaccine experts, we argue the government response should be broadened in three ...